11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval

11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...

11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...

11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...

11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...

11/4/2024Big Pharma Doubles Down on China (The Wire China)

11/4/2024CARsgen and Galapagos Resume CAR-T Trials Following Regulatory Pauses

11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...

11/4/2024Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescim...

11/4/2024Hangzhou Reprogenix Secures Over CNY 100M in Series A Funding, Advanci...

11/4/2024CureGene Completes Series B+ Financing, Advancing Cardiovascular and A...

11/4/2024US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA

11/4/2024NeuroDawn Completes Series C Financing to Advance CNS Drug Pipeline

11/4/2024Saudi FDA Chief Highlights Investment Opportunities for Chinese Cos in...

11/4/2024China Targets AstraZeneca in BMI Fraud Probe over Tagrisso

11/4/2024BIOSECURE Act May Shift Biopharma Manufacturing from China to India, S...

11/4/2024The 10th Round of National Level VBP of Drugs Officially Initiated wit...

11/4/2024NMPA Signs Letter of Intent on Cooperation with Danish Medicines Agenc...

11/4/2024Li Li Meets with Head of Brazil's Health Regulatory Agency

11/1/2024U.S. Drugmakers Seek Alternatives to Chinese Supply Chains Amid Rising...

11/1/2024Hengrui Pharma Weighs Hong Kong IPO to Drive Global Expansion

11/1/2024Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...

11/1/2024Global Biotech Supply Chain: A Shift Away from China and Opportunities...

11/1/2024Shanghai Unveils Initiative to Boost Local Biopharma's Global Expansio...

11/1/2024NHC Minister Engages in Video Conference with WHO Director-General

11/1/2024NMPA Issues Announcement for Applicability of ICH Guideline M12

11/1/2024Recent Executive Moves

10/31/2024CDE Issues the List of Reference Formulations for GQCE Studies (84th B...

10/31/2024CStone Announces MHRA Approval of Sugemalimab for First-Line NSCLC Tre...

10/31/2024AllianThera's IND for IBD Candidate ATB102 Cleared by the USFDA

Page:41/774 Total number of articles:23207: [First][<<] [39] [40] [41] [42] [43] [>>] [End]